News & Updates

Show Multimedia Only

Ozoralizumab shows therapeutic potential in rheumatoid arthritis

13 Jul 2022

Treatment with the next-generation anti-TNFα antibody yields marked improvements in the signs and symptoms of rheumatoid arthritis in patients with inadequate response to methotrexate (MTX), while having an acceptable safety profile, as shown in the phase II/III OHZORA trial.

13 Jul 2022

An aspirin a day does not keep melanoma at bay

13 Jul 2022

Taking aspirin daily appears to do nothing in terms of reducing the risk of cutaneous melanoma in older individuals, according to a study.

13 Jul 2022

More than 6 in 10 hospitalized diabetics have obstructive sleep apnoea

12 Jul 2022

Obstructive sleep apnoea syndrome (OSAS) is common among hospitalized patients with type 2 diabetes mellitus (T2DM), afflicting over 60 percent of this patient population, a recent China study has found.

12 Jul 2022

SGLT2 inhibitors provide renoprotection in Asians

12 Jul 2022 by

Real-world use of sodium-glucose cotransporter 2 (SGLT2) inhibitors can stem the progression of chronic kidney disease (CKD) and the development of end-stage kidney disease (ESKD) in a multi-ethnic Asian population, according to a study.

12 Jul 2022

Ventral striatum connectivity may predict depression in adolescence

12 Jul 2022

The connectivity strength of the ventral striatum (VS) within the reward network demonstrates links to depressive disorders and anhedonia from mid to late adolescence, which indicates the role played by this circuitry in depression changes with age, reveals a study.

12 Jul 2022

Artificial iris device proven safe, effective for iris defects

12 Jul 2022 by

A custom-manufactured artificial iris device has exceeded all safety outcomes for adverse events associated with the device, intraocular lens (IOL), or implant surgery, reports a study. It has also shown its efficacy as indicated by decreased light and glare sensitivity, better health-related quality of life, and cosmetic satisfaction among patients with iris defects.

12 Jul 2022

Solithromycin safe, effective in paediatric community-acquired bacterial pneumonia

12 Jul 2022

Treatment with intravenous or oral solithromycin is well-tolerated and leads to clinical improvement in most children and adolescents with community-acquired bacterial pneumonia (CABP), results of a recent study have shown.

12 Jul 2022

Can very low-risk breast cancer patients be spared from postop radiotherapy?

12 Jul 2022 by

Adjuvant radiotherapy (RT) may be omitted in women with very low-risk breast cancer who have had breast conserving surgery (BCS) and have been receiving endocrine therapy, according to findings from the LUMINA study.